India, Nov. 13 -- London (PAMedia/dpa) - Scientists have created the first new anti-malaria drug in quarter of a century in a bid to cut out resistance to existing treatments. Researchers found their new treatment has a "very high cure rate" of more than 97.4% - and in some assessments over 99.2%. Experts said that they were "very excited" by the findings. "This has a potential to not just treat the disease, but also to work against the resistant parasites, [and] additionally, block the transmission of the disease," said Dr Sujata Vaidyanathan, head of global health development at Novartis, which created the new drug. The treatment, known as GanLum, works by disrupting the internal protein transport system in the malaria parasite - which is...